NRXP Stock Analysis: Buy, Sell, or Hold?
NRXP - NRX Pharmaceuticals, Inc. Common Stock
$2.08
-0.11 (-5.25%)
▼
5d:
+17.23%
30d:
+11.56%
90d:
-18.95%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 21, 2026
Smart Money Accumulation
NRXP is down 4.5% this week, but smart money is accumulating calls. Top strike: $2.5 2026-04-17 with 5 OI. Call ratio: 100% View Scanner →
Strength: 7.3/10
Get Alerted When NRXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NRXP trades at premium valuation expecting 6.9% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: NRXP trades at premium valuation expecting 6.9% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: NRXP is currently trading at $2.08, which is considered extended relative to its 30-day fair value range of $1.72 to $2.06. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.9) compared to its historical average (13.8). At these levels, the market is pricing in 6.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NRXP is in a strong downtrend. Immediate support is located at $1.72, while resistance sits at $2.49. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: NRXP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $38.00 (+1635.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NRXP is in a strong downtrend. Immediate support is located at $1.72, while resistance sits at $2.49. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: NRXP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $38.00 (+1635.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.72 -
$2.06
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.2%
Protect Your Profits
Holding NRXP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.3%)
- BULLISH: Trading 1635.2% below Wall St target ($38.00)
- NEUTRAL: Trading at premium valuation - market expects 6.9% growth which is achievable
Fair Price Analysis
30-Day Fair Range
$1.72 -
$2.06
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.72
Resistance Level
$2.49
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.85
Wall Street Target
$38.00
(+1635.2%)
Valuation Premium vs History
+6.9% premium
PE vs Historical
16.9 vs 13.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.9%
(market-implied from PE analysis)
1-Year Target
$2.34
(+7%)
2-Year Target
$2.50
(+14%)
3-Year Target
$2.68
(+22%)
3-Yr Target (if PE normalizes)
(PE: 17→14)
PE COMPRESSION
$2.19
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: March 30, 2026 3:22 PM ET
Data refreshes hourly during market hours. Next update: 4:21 PM
Data refreshes hourly during market hours. Next update: 4:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 56 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 63 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 45 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 54 HOLD |
Advanced NRXP Option Strategies
Professional options setups generated by AI based on today's NRXP price and gamma walls.
